Ontology type: schema:ScholarlyArticle Open Access: True
2005-01
AUTHORSV. K. Puduvalli, D. Sampath, J. M. Bruner, J. Nangia, R. Xu, A. P. Kyritsis
ABSTRACTPatients with malignant gliomas have a poor prognosis and new treatment paradigms are needed against this disease. TRAIL/Apo2L selectively induces apoptosis in malignant cells sparing normal cells and is hence of interest as a potential therapeutic agent against gliomas. To determine the factors that modulate sensitivity to TRAIL, we examined the differences in TRAIL-activated signaling pathways in glioma cells with variable sensitivities to the agent. Apoptosis in response to TRAIL was unrelated to DR5 expression or endogenous p53 status in a panel of 8 glioma cell lines. TRAIL activated the extrinsic (cleavage of caspase-8, caspase-3 and PARP) and mitochondrial apoptotic pathways and reduced FLIP levels. It also induced caspase-dependent JNK activation, which did not influence TRAIL-induced apoptosis. Because the pro-survival PI3K/Akt pathway is highly relevant to gliomas, we assessed whether Akt could protect against TRAIL-induced apoptosis. Pretreatment with SH-6, a novel Akt inhibitor, enhanced TRAIL-induced apoptosis, suggesting a protective role for Akt. Conversely, TRAIL induced caspase-dependent cleavage of Akt neutralizing its anti-apoptotic effects. These results demonstrate that TRAIL-induced apoptosis in gliomas involves both activation of death pathways and downregulation of survival pathways. Additional studies are warranted to determine the therapeutic potential of TRAIL against gliomas. More... »
PAGES233-243
http://scigraph.springernature.com/pub.10.1007/s10495-005-6078-3
DOIhttp://dx.doi.org/10.1007/s10495-005-6078-3
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1046921353
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/15711939
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Oncology and Carcinogenesis",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Apoptosis",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Apoptosis Regulatory Proteins",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Cell Line, Tumor",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Enzyme Activation",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Glioma",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Humans",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "JNK Mitogen-Activated Protein Kinases",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "MAP Kinase Kinase 4",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Membrane Glycoproteins",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Mitogen-Activated Protein Kinase Kinases",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Protein-Serine-Threonine Kinases",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Proto-Oncogene Proteins",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Proto-Oncogene Proteins c-akt",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Signal Transduction",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "TNF-Related Apoptosis-Inducing Ligand",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Tumor Necrosis Factor-alpha",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Departments of Neuro-Oncology, The University of Texas M. D. Anderson Cancer Center, 7700, Houston, TX, USA",
"id": "http://www.grid.ac/institutes/grid.240145.6",
"name": [
"Departments of Neuro-Oncology, The University of Texas M. D. Anderson Cancer Center, 7700, Houston, TX, USA"
],
"type": "Organization"
},
"familyName": "Puduvalli",
"givenName": "V. K.",
"id": "sg:person.01156403355.42",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01156403355.42"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Experimental Therapeutics, The University of Texas M. D. Anderson Cancer Center, 7700, Houston, TX, USA",
"id": "http://www.grid.ac/institutes/grid.240145.6",
"name": [
"Experimental Therapeutics, The University of Texas M. D. Anderson Cancer Center, 7700, Houston, TX, USA"
],
"type": "Organization"
},
"familyName": "Sampath",
"givenName": "D.",
"id": "sg:person.01231612071.24",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01231612071.24"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Pathology, The University of Texas M. D. Anderson Cancer Center, 7700, Houston, TX, USA",
"id": "http://www.grid.ac/institutes/grid.240145.6",
"name": [
"Pathology, The University of Texas M. D. Anderson Cancer Center, 7700, Houston, TX, USA"
],
"type": "Organization"
},
"familyName": "Bruner",
"givenName": "J. M.",
"id": "sg:person.013375073077.30",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013375073077.30"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Departments of Neuro-Oncology, The University of Texas M. D. Anderson Cancer Center, 7700, Houston, TX, USA",
"id": "http://www.grid.ac/institutes/grid.240145.6",
"name": [
"Departments of Neuro-Oncology, The University of Texas M. D. Anderson Cancer Center, 7700, Houston, TX, USA"
],
"type": "Organization"
},
"familyName": "Nangia",
"givenName": "J.",
"type": "Person"
},
{
"affiliation": {
"alternateName": "Departments of Neuro-Oncology, The University of Texas M. D. Anderson Cancer Center, 7700, Houston, TX, USA",
"id": "http://www.grid.ac/institutes/grid.240145.6",
"name": [
"Departments of Neuro-Oncology, The University of Texas M. D. Anderson Cancer Center, 7700, Houston, TX, USA"
],
"type": "Organization"
},
"familyName": "Xu",
"givenName": "R.",
"id": "sg:person.01352651714.56",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01352651714.56"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Neurology, University of Ioaninna, Ioaninna, Greece",
"id": "http://www.grid.ac/institutes/None",
"name": [
"Department of Neurology, University of Ioaninna, Ioaninna, Greece"
],
"type": "Organization"
},
"familyName": "Kyritsis",
"givenName": "A. P.",
"id": "sg:person.014354466417.30",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014354466417.30"
],
"type": "Person"
}
],
"citation": [
{
"id": "sg:pub.10.1038/sj.onc.1203453",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1050239579",
"https://doi.org/10.1038/sj.onc.1203453"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/5517",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1010598958",
"https://doi.org/10.1038/5517"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/sj.onc.1202702",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1036436500",
"https://doi.org/10.1038/sj.onc.1202702"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/sj.onc.1204736",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1011680283",
"https://doi.org/10.1038/sj.onc.1204736"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/sj.onc.1203700",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1014822552",
"https://doi.org/10.1038/sj.onc.1203700"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/sj.onc.1202561",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1046556077",
"https://doi.org/10.1038/sj.onc.1202561"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/sj.cdd.4400467",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1015301816",
"https://doi.org/10.1038/sj.cdd.4400467"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/376785a0",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1022545215",
"https://doi.org/10.1038/376785a0"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/380075a0",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1029942479",
"https://doi.org/10.1038/380075a0"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/sj.onc.1204282",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1014003480",
"https://doi.org/10.1038/sj.onc.1204282"
],
"type": "CreativeWork"
}
],
"datePublished": "2005-01",
"datePublishedReg": "2005-01-01",
"description": "Patients with malignant gliomas have a poor prognosis and new treatment paradigms are needed against this disease. TRAIL/Apo2L selectively induces apoptosis in malignant cells sparing normal cells and is hence of interest as a potential therapeutic agent against gliomas. To determine the factors that modulate sensitivity to TRAIL, we examined the differences in TRAIL-activated signaling pathways in glioma cells with variable sensitivities to the agent. Apoptosis in response to TRAIL was unrelated to DR5 expression or endogenous p53 status in a panel of 8 glioma cell lines. TRAIL activated the extrinsic (cleavage of caspase-8, caspase-3 and PARP) and mitochondrial apoptotic pathways and reduced FLIP levels. It also induced caspase-dependent JNK activation, which did not influence TRAIL-induced apoptosis. Because the pro-survival PI3K/Akt pathway is highly relevant to gliomas, we assessed whether Akt could protect against TRAIL-induced apoptosis. Pretreatment with SH-6, a novel Akt inhibitor, enhanced TRAIL-induced apoptosis, suggesting a protective role for Akt. Conversely, TRAIL induced caspase-dependent cleavage of Akt neutralizing its anti-apoptotic effects. These results demonstrate that TRAIL-induced apoptosis in gliomas involves both activation of death pathways and downregulation of survival pathways. Additional studies are warranted to determine the therapeutic potential of TRAIL against gliomas.",
"genre": "article",
"id": "sg:pub.10.1007/s10495-005-6078-3",
"inLanguage": "en",
"isAccessibleForFree": true,
"isFundedItemOf": [
{
"id": "sg:grant.2478133",
"type": "MonetaryGrant"
},
{
"id": "sg:grant.2435611",
"type": "MonetaryGrant"
}
],
"isPartOf": [
{
"id": "sg:journal.1117236",
"issn": [
"1360-8185",
"1573-675X"
],
"name": "Apoptosis",
"publisher": "Springer Nature",
"type": "Periodical"
},
{
"issueNumber": "1",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "10"
}
],
"keywords": [
"TRAIL-induced apoptosis",
"new treatment paradigm",
"TRAIL/Apo2L",
"PI3K/Akt pathway",
"potential therapeutic agent",
"anti-apoptotic effect",
"endogenous p53 status",
"novel Akt inhibitor",
"glioma cell lines",
"poor prognosis",
"treatment paradigm",
"JNK activation",
"malignant gliomas",
"protective role",
"malignant cells",
"therapeutic potential",
"gliomas",
"DR5 expression",
"therapeutic agents",
"glioma cells",
"p53 status",
"Additional studies",
"Akt pathway",
"Akt inhibitor",
"Akt inhibition",
"survival pathways",
"FLIP levels",
"mitochondrial apoptotic pathway",
"cell lines",
"apoptosis",
"SH-6",
"Akt",
"normal cells",
"apoptotic pathway",
"variable sensitivity",
"activation",
"death pathways",
"cells",
"pathway",
"patients",
"prognosis",
"agents",
"caspase-dependent cleavage",
"disease",
"downregulation",
"Apo2L",
"inhibitors",
"sensitivity",
"pretreatment",
"trails",
"status",
"expression",
"response",
"factors",
"levels",
"differences",
"study",
"role",
"effect",
"panel",
"lines",
"potential",
"results",
"cleavage",
"paradigm",
"interest",
"reduced FLIP levels",
"caspase-dependent JNK activation",
"pro-survival PI3K/Akt pathway"
],
"name": "TRAIL-induced apoptosis in gliomas is enhanced by Akt-inhibition and is independent of JNK activation",
"pagination": "233-243",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1046921353"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1007/s10495-005-6078-3"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"15711939"
]
}
],
"sameAs": [
"https://doi.org/10.1007/s10495-005-6078-3",
"https://app.dimensions.ai/details/publication/pub.1046921353"
],
"sdDataset": "articles",
"sdDatePublished": "2022-01-01T18:15",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_411.jsonl",
"type": "ScholarlyArticle",
"url": "https://doi.org/10.1007/s10495-005-6078-3"
}
]Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10495-005-6078-3'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10495-005-6078-3'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10495-005-6078-3'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10495-005-6078-3'
This table displays all metadata directly associated to this object as RDF triples.
280 TRIPLES
22 PREDICATES
122 URIs
104 LITERALS
23 BLANK NODES